The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Rinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Kwekkeboom, D. J., de Herder, W. W., Kam, B. L., van Eijck, C. H., van Essen, M., Kooij, P. P., Feelders, R. A., van Aken, M. O., & Krenning, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2553 · Cited by 1,456
Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035667 · Cited by 1,010
Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
Kwekkeboom, D. J., Kam, B. L., van Essen, M., Teunissen, J. J. M., van Eijck, C. H. J., Valkema, R., de Jong, M., de Herder, W. W., & Krenning, E. P. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0078 · Cited by 466
Virgolini, I., Ambrosini, V., Bomanji, J. B., Baum, R. P., Fanti, S., Gabriel, M., Papathanasiou, N. D., Pepe, G., Oyen, W., De Cristoforo, C., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1512-3 · Cited by 442
Bodei, L., Cremonesi, M., Ferrari, M., Pacifici, M., Grana, C. M., Bartolomei, M., Baio, S. M., Sansovini, M., & Paganelli, G. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0778-1 · Cited by 428
Self-citationValkema, R., Pauwels, S. A., Kvols, L. K., Kwekkeboom, D. J., Jamar, F., de Jong, M., Barone, R., Walrand, S., Kooij, P. P. M., Bakker, W. H., et al. (2005) · PubMed · Cited by 379
Barone, R., Borson‐Chazot, F., Valkema, R., Walrand, S., Chauvin, F., Gogou, L., Kvols, L. K., Krenning, E. P., Jamar, F., & Pauwels, S. A. (2005) · PubMed · Cited by 289
Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials
Bryant, J., & Day, R. (1995) · Biometrics · doi:10.2307/2533268 · Cited by 260
Dosimetry in Peptide radionuclide receptor therapy: a review.
Cremonesi, M., Ferrari, M. E., Bodei, L., Tosi, G., & Paganelli, G. (2006) · PubMed · Cited by 260
Self-citation68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
Ambrosini, V., Campana, D., Bodei, L., Nanni, C., Castellucci, P., Allegri, V., Montini, G. C., Tomassetti, P., Paganelli, G., & Fanti, S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.071712 · Cited by 232
Self-citationTeunissen, J. J. M., Kwekkeboom, D. J., & Krenning, E. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.016 · Cited by 197
Wessels, B. W., Konijnenberg, M. W., Dale, R. G., Breitz, H. B., Cremonesi, M., Meredith, R. F., Green, A. J., Bouchet, L. G., Brill, A. B., Bolch, W. E., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.053173 · Cited by 194
Self-citationPeptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
Bartolomei, M., Bodei, L., Cicco, C. D., Grana, C. M., Cremonesi, M., Botteri, E., Baio, S. M., Aricò, D., Sansovini, M., & Paganelli, G. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1115-z · Cited by 155
Self-citationPeptide receptor therapies in neuroendocrine tumors
Bodei, L., Ferone, D., Grana, C. M., Cremonesi, M., Signore, A., Dierckx, R. A., & Paganelli, G. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345728 · Cited by 124
Self-citation(2010) · PubMed · Cited by 102
Dale, R. (2004) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/1084978041425070 · Cited by 91
Peptide Receptor Radionuclide Therapy in a Case of Multiple Spinal Canal and Cranial Paragangliomas
Cecchin, D., Schiavi, F., Fanti, S., Favero, M., Manara, R., Fassina, A., Briani, C., Allegri, V., Sansovini, M., Bui, F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.7131 · Cited by 22
Self-citationRadionuclide Peptide Cancer Therapy
(2013) · CRC Press eBooks · doi:10.3109/9781420016727 · Cited by 21
Davì, M. V., Bodei, L., Ferdeghini, M., Falconi, M., Testoni, M., Paganelli, G., Oliani, C., Cascio, V. L., & Francia, G. (2008) · Endocrine Practice · doi:10.4158/ep.14.2.213 · Cited by 13
Self-citation
Cited by
Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors
Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607427 · Cited by 3,308
Brabander, T., van der Zwan, W. A., Teunissen, J. J. M., Kam, B. L. R., Feelders, R. A., de Herder, W. W., van Eijck, C. H. J., Franssen, G. J. H., Krenning, E. P., & Kwekkeboom, D. J. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2743 · Cited by 614
Strosberg, J. R., Caplin, M. E., Kunz, P. L., Ruszniewski, P. B., Bodei, L., Hendifar, A., Mittra, E., Wolin, E. M., Yao, J. C., Pavel, M. E., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00572-6 · Cited by 578
Self-citationBodei, L., Kidd, M., Paganelli, G., Grana, C. M., Drozdov, I., Cremonesi, M., Lepensky, C., Kwekkeboom, D. J., Baum, R. P., Krenning, E. P., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2893-5 · Cited by 465
“It is generally considered, however, that an increase in creatinine values after PRRT reflects a decrease in creatinine clearance, since there is a decrease in renal function following the therapy [3, 13, 14, 25].”
BackgroundSelf-citationProduction of 177Lu for Targeted Radionuclide Therapy: Available Options
Dash, A., Pillai, M. R. A., & Knapp, F. F. (2015) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-014-0315-z · Cited by 386
Metadata
- Authors
- Bodei, L., Cremonesi, M., Grana, C. M., Fazio, N., Iodice, S., Baio, S. M., Bartolomei, M., Lombardo, D., Ferrari, M. E., Sansovini, M., Chinol, M., & Paganelli, G.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2011-09-03
- Volume
- 38
- Issue
- 12
- Pages
- 2125-2135
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2027676394
- Cited by
- 424
- References
- 24
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.